Human Endogenous Retroviruses in Neurological Diseases

Hayes, 2013, Pathological and evolutionary implications of retroviruses as mobile genetic elements, Genes, 4, 573, 10.3390/genes4040573 Babatz, 2013, Functional impact of the human mobilome, Curr. Opin. Genet. Dev., 23, 264, 10.1016/j.gde.2013.02.007 Pace, 2007, The evolutionary history of human DNA transposons: evidence for intense activity in the primate lineage, Genome Res., 17, 422, 10.1101/gr.5826307 Katzourakis, 2010, Endogenous viral elements in animal genomes, PLoS Genet., 6, 10.1371/journal.pgen.1001191 Feschotte, 2012, Endogenous viruses: insights into viral evolution and impact on host biology, Nat. Rev. Genet., 13, 283, 10.1038/nrg3199 Chuong, 2016, Regulatory evolution of innate immunity through co-option of endogenous retroviruses, Science, 351, 1083, 10.1126/science.aad5497 Bonnaud, 2004, Evidence of selection on the domesticated ERVWE1 env retroviral element involved in placentation, Mol. Biol. Evol., 21, 1895, 10.1093/molbev/msh206 Engel, 2010, The enemy within: dormant retroviruses awaken, Nat. Med., 16, 517, 10.1038/nm0510-517 Volkman, 2014, The enemy within: endogenous retroelements and autoimmune disease, Nat. Immunol., 15, 415, 10.1038/ni.2872 Perron, 2012, Molecular characteristics of human endogenous retrovirus type-W in schizophrenia and bipolar disorder, Transl. Psychiatry, 2, e201, 10.1038/tp.2012.125 Levet, 2017, An ancestral retroviral protein identified as a therapeutic target in type-1 diabetes, JCI Insight, 2, 10.1172/jci.insight.94387 Criscione, 2014, Transcriptional landscape of repetitive elements in normal and cancer human cells, BMC Genomics, 15, 583, 10.1186/1471-2164-15-583 Liang, 2012, Database documentation of retrotransposon insertion polymorphisms, Front. Biosci., 4, 1542, 10.2741/e479 Hedges, 2011, Restless genomes: humans as a model organism for understanding host–retrotransposable element dynamics, Adv. Genet., 73, 219, 10.1016/B978-0-12-380860-8.00006-9 Medina, 2017, DNA sequences from mobile genetic elements, a hidden half of the human genome, Med. Sci., 33, 151 Hancks, 2016, Roles for retrotransposon insertions in human disease, Mob. DNA, 7, 9, 10.1186/s13100-016-0065-9 Nishibuchi, 2017, The molecular basis of the organization of repetitive DNA-containing constitutive heterochromatin in mammals, Chromosome Res., 25, 77, 10.1007/s10577-016-9547-3 Campos-Sanchez, 2014, Genomic landscape of human, bat, and ex vivo DNA transposon integrations, Mol. Biol. Evol., 31, 1816, 10.1093/molbev/msu138 Belshaw, 2004, Long-term reinfection of the human genome by endogenous retroviruses, Proc. Natl. Acad. Sci. U. S. A., 101, 4894, 10.1073/pnas.0307800101 van de Lagemaat, 2006, Multiple effects govern endogenous retrovirus survival patterns in human gene introns, Genome Biol., 7, R86, 10.1186/gb-2006-7-9-r86 Serra, 2003, In vitro modulation of the multiple sclerosis (MS)-associated retrovirus by cytokines: implications for MS pathogenesis, J. Neurovirol., 9, 637 Uleri, 2014, HIV Tat acts on endogenous retroviruses of the W family and this occurs via Toll-like receptor 4: inference for neuroAIDS, AIDS, 28, 2659, 10.1097/QAD.0000000000000477 Petersen, 2009, Effects of interferon-beta therapy on innate and adaptive immune responses to the human endogenous retroviruses HERV-H and HERV-W, cytokine production, and the lectin complement activation pathway in multiple sclerosis, J. Neuroimmunol., 215, 108, 10.1016/j.jneuroim.2009.08.015 Mameli, 2008, Inhibition of multiple-sclerosis-associated retrovirus as biomarker of interferon therapy, J. Neurovirol., 14, 73, 10.1080/13550280701801107 Perron, 1993, Herpes simplex virus ICP0 and ICP4 immediate early proteins strongly enhance expression of a retrovirus harboured by a leptomeningeal cell line from a patient with multiple sclerosis, J. Gen. Virol., 74, 65, 10.1099/0022-1317-74-1-65 Brudek, 2007, Activation of endogenous retrovirus reverse transcriptase in multiple sclerosis patient lymphocytes by inactivated HSV-1, HHV-6 and VZV, J. Neuroimmunol., 187, 147, 10.1016/j.jneuroim.2007.04.003 Ruprecht, 2006, Regulation of human endogenous retrovirus W protein expression by herpes simplex virus type 1: implications for multiple sclerosis, J. Neurovirol., 12, 65, 10.1080/13550280600614973 Bergallo, 2015, CMV induces HERV-K and HERV-W expression in kidney transplant recipients, J. Clin. Virol., 68, 28, 10.1016/j.jcv.2015.04.018 Tai, 2009, HHV-6A infection induces expression of HERV-K18–encoded superantigen, J. Clin. Virol., 46, 47, 10.1016/j.jcv.2009.05.019 Sutkowski, 2001, Epstein–Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen, Immunity, 15, 579, 10.1016/S1074-7613(01)00210-2 Mameli, 2012, Expression and activation by Epstein–Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis, PLoS One, 7, 10.1371/journal.pone.0044991 Leibovitch, 2018, Viruses in chronic progressive neurologic disease, Mult. Scler., 24, 48, 10.1177/1352458517737392 Morahan, 1989, Molecular localization of abortive infection of resident peritoneal macrophages by herpes simplex virus type 1, J. Virol., 63, 2300, 10.1128/jvi.63.5.2300-2307.1989 Hammerschmidt, 2015, The epigenetic life cycle of Epstein–Barr virus, Curr. Top. Microbiol. Immunol., 390, 103 Ascherio, 2010, Epstein–Barr virus infection and multiple sclerosis: a review, J. Neuroimmune Pharmacol., 5, 271, 10.1007/s11481-010-9201-3 Mameli, 2013, Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein–Barr virus latency: the missing link with multiple sclerosis?, PLoS One, 8, 10.1371/journal.pone.0078474 Toufaily, 2011, Activation of LTRs from different human endogenous retrovirus (HERV) families by the HTLV-1 tax protein and T-cell activators, Viruses, 3, 2146, 10.3390/v3112146 Perron, 2001, Multiple sclerosis retrovirus particles and recombinant envelope trigger an abnormal immune response in vitro, by inducing polyclonal Vbeta16 T-lymphocyte activation, Virology, 287, 321, 10.1006/viro.2001.1045 Perron, 2013, Human endogenous retrovirus protein activates innate immunity and promotes experimental allergic encephalomyelitis in mice, PLoS One, 8, 10.1371/journal.pone.0080128 Dendrou, 2015, Immunopathology of multiple sclerosis, Nat. Rev. Immunol., 15, 545, 10.1038/nri3871 Petereit, 2005, Expansion of antibody reactivity in the cerebrospinal fluid of multiple sclerosis patients – follow-up and clinical implications, Cerebrospinal Fluid Res., 2, 3, 10.1186/1743-8454-2-3 Mahad, 2015, Pathological mechanisms in progressive multiple sclerosis, Lancet Neurol., 14, 183, 10.1016/S1474-4422(14)70256-X Rocha, 1995, Anergy and exhaustion are independent mechanisms of peripheral T cell tolerance, J. Exp. Med., 181, 993, 10.1084/jem.181.3.993 Illingworth, 2013, Chronic exposure to Plasmodium falciparum is associated with phenotypic evidence of B and T cell exhaustion, J. Immunol., 190, 1038, 10.4049/jimmunol.1202438 Hollenbach, 2015, The immunogenetics of multiple sclerosis: a comprehensive review, J. Autoimmun., 64, 13, 10.1016/j.jaut.2015.06.010 Belbasis, 2015, Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses, Lancet Neurol., 14, 263, 10.1016/S1474-4422(14)70267-4 Hedstrom, 2016, Environmental factors and their interactions with risk genotypes in MS susceptibility, Curr. Opin. Neurol., 29, 293, 10.1097/WCO.0000000000000329 Renz, 2011, Gene–environment interactions in chronic inflammatory disease, Nat. Immunol., 12, 273, 10.1038/ni0411-273 McKay, 2015, Risk factors associated with the onset of relapsing-remitting and primary progressive multiple sclerosis: a systematic review, BioMed Res. Int., 2015, 10.1155/2015/817238 Nissen, 2012, No additional copies of HERV-Fc1 in the germ line of multiple sclerosis patients, Virol. J., 9, 188, 10.1186/1743-422X-9-188 Hansen, 2011, Genetic association of multiple sclerosis with the marker rs391745 near the endogenous retroviral locus HERV-Fc1: analysis of disease subtypes, PLoS One, 6, 10.1371/journal.pone.0026438 Muradrasoli, 2006, Development of real-time PCRs for detection and quantitation of human MMTV-like (HML) sequences HML expression in human tissues, J. Virol. Methods, 136, 83, 10.1016/j.jviromet.2006.04.005 Christensen, 2000, Molecular characterization of HERV-H variants associated with multiple sclerosis, Acta Neurol. Scand., 101, 229, 10.1034/j.1600-0404.2000.101004229.x Brudek, 2009, B cells and monocytes from patients with active multiple sclerosis exhibit increased surface expression of both HERV-H Env and HERV-W Env, accompanied by increased seroreactivity, Retrovirology, 6, 104, 10.1186/1742-4690-6-104 Christensen, 2016, Human endogenous retroviruses in neurologic disease, APMIS, 124, 116, 10.1111/apm.12486 Morandi, 2017, The association between human endogenous retroviruses and multiple sclerosis: a systematic review and meta-analysis, PLoS One, 12, 10.1371/journal.pone.0172415 Perron, 1989, Leptomeningeal cell line from multiple sclerosis with reverse transcriptase activity and viral particles, Res. Virol., 140, 551, 10.1016/S0923-2516(89)80141-4 Perron, 1991, Isolation of retrovirus from patients with multiple sclerosis, Lancet, 337, 862, 10.1016/0140-6736(91)92579-Q Komurian-Pradel, 1999, Molecular cloning and characterization of MSRV-related sequences associated with retrovirus-like particles, Virology, 260, 1, 10.1006/viro.1999.9792 Perron, 1997, Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis, Proc. Natl. Acad. Sci. U. S. A., 94, 7583, 10.1073/pnas.94.14.7583 Tuke, 1997, Development of a pan-retrovirus detection system for multiple sclerosis studies, Acta Neurol. Scand. Suppl., 169, 16, 10.1111/j.1600-0404.1997.tb08145.x Blond, 1999, Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family, J. Virol., 73, 1175, 10.1128/JVI.73.2.1175-1185.1999 Mameli, 2007, Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MS-associated retrovirus/HERV-W endogenous retrovirus, but not human herpesvirus 6, J. Gen. Virol., 88, 264, 10.1099/vir.0.81890-0 Perron, 2012, Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease, Mult. Scler., 18, 1721, 10.1177/1352458512441381 Sotgiu, 2010, Multiple sclerosis-associated retrovirus and progressive disability of multiple sclerosis, Mult. Scler., 16, 1248, 10.1177/1352458510376956 Garson, 1998, Detection of virion-associated MSRV-RNA in serum of patients with multiple sclerosis, Lancet, 351, 33, 10.1016/S0140-6736(98)24001-3 Garcia-Montojo, 2013, The DNA copy number of human endogenous retrovirus-W (MSRV-type) is increased in multiple sclerosis patients and is influenced by gender and disease severity, PLoS One, 8, 10.1371/journal.pone.0053623 Kremer, 2013, Human endogenous retrovirus type W envelope protein inhibits oligodendroglial precursor cell differentiation, Ann. Neurol., 74, 721, 10.1002/ana.23970 van Horssen, 2016, Human endogenous retrovirus W in brain lesions: rationale for targeted therapy in multiple sclerosis, Mult. Scler. Relat. Disord., 8, 11, 10.1016/j.msard.2016.04.006 Rolland, 2006, The envelope protein of a human endogenous retrovirus-W family activates innate immunity through CD14/TLR4 and promotes Th1-like responses, J. Immunol., 176, 7636, 10.4049/jimmunol.176.12.7636 Saresella, 2009, Multiple sclerosis-associated retroviral agent (MSRV)-stimulated cytokine production in patients with relapsing-remitting multiple sclerosis, Mult. Scler., 15, 443, 10.1177/1352458508100840 Kremer, 2015, The neutralizing antibody GNbAC1 abrogates HERV-W envelope protein-mediated oligodendroglial maturation blockade, Mult. Scler., 21, 1200, 10.1177/1352458514560926 Curtin, 2015, Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein, MAbs, 7, 265, 10.4161/19420862.2014.985021 Duperray, 2015, Inflammatory response of endothelial cells to a human endogenous retrovirus associated with multiple sclerosis is mediated by TLR4, Int. Immunol., 27, 545, 10.1093/intimm/dxv025 Curtin, 2016, Serum pharmacokinetics and cerebrospinal fluid concentration analysis of the new IgG4 monoclonal antibody GNbAC1 to treat multiple sclerosis: a Phase 1 study, MAbs, 8, 854, 10.1080/19420862.2016.1168956 Derfuss, 2015, A phase IIa randomized clinical study testing GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis associated endogenous retrovirus in multiple sclerosis patients – a twelve month follow-up, J. Neuroimmunol., 285, 68, 10.1016/j.jneuroim.2015.05.019 Curtin, 2012, GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus: a first-in-humans randomized clinical study, Clin. Ther., 34, 2268, 10.1016/j.clinthera.2012.11.006 Curtin, 2016, A placebo randomized controlled study to test the efficacy and safety of GNbAC1, a monoclonal antibody for the treatment of multiple sclerosis – rationale and design, MSARD, 9, 95 Maruszak, 2011, Could antiretroviral drugs be effective in multiple sclerosis? A case report, Eur. J. Neurol., 18, e110, 10.1111/j.1468-1331.2011.03430.x Faucard, 2016, Human endogenous retrovirus and neuroinflammation in chronic inflammatory demyelinating polyradiculoneuropathy, EBioMedicine, 6, 190, 10.1016/j.ebiom.2016.03.001 Viola, 1975, RNA-instructed DNA polymerase activity in a cytoplasmic particulate fraction in brains from Guamanian patients, J. Exp. Med., 142, 483, 10.1084/jem.142.2.483 Andrews, 2000, Detection of reverse transcriptase activity in the serum of patients with motor neurone disease, J. Med. Virol., 61, 527, 10.1002/1096-9071(200008)61:4<527::AID-JMV17>3.0.CO;2-A McCormick, 2008, Quantification of reverse transcriptase in ALS and elimination of a novel retroviral candidate, Neurology, 70, 278, 10.1212/01.wnl.0000297552.13219.b4 Steele, 2005, Detection of serum reverse transcriptase activity in patients with ALS and unaffected blood relatives, Neurology, 64, 454, 10.1212/01.WNL.0000150899.76130.71 Kim, 2010, No evidence of HIV pol gene in spinal cord tissues in sporadic ALS by real-time RT-PCR, Amyotroph. Lateral Scler., 11, 91, 10.3109/17482960902835988 Douville, 2011, Identification of active loci of a human endogenous retrovirus in neurons of patients with amyotrophic lateral sclerosis, Ann. Neurol., 69, 141, 10.1002/ana.22149 Li, 2015, Human endogenous retrovirus-K contributes to motor neuron disease, Sci. Transl. Med., 7, 10.1126/scitranslmed.aac8201 Belshaw, 2005, Genomewide screening reveals high levels of insertional polymorphism in the human endogenous retrovirus family HERV-K(HML2): implications for present-day activity, J. Virol., 79, 12507, 10.1128/JVI.79.19.12507-12514.2005 Subramanian, 2011, Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses, Retrovirology, 8, 90, 10.1186/1742-4690-8-90 Marchi, 2014, Unfixed endogenous retroviral insertions in the human population, J. Virol., 88, 9529, 10.1128/JVI.00919-14 Wildschutte, 2016, Discovery of unfixed endogenous retrovirus insertions in diverse human populations, Proc. Natl. Acad. Sci. U. S. A., 113, E2326, 10.1073/pnas.1602336113 Lee, 2007, Reconstitution of an infectious human endogenous retrovirus, PLoS Pathog., 3, e10, 10.1371/journal.ppat.0030010 Goke, 2015, Dynamic transcription of distinct classes of endogenous retroviral elements marks specific populations of early human embryonic cells, Cell Stem Cell, 16, 135, 10.1016/j.stem.2015.01.005 Igaz, 2011, Dysregulation of the ALS-associated gene TDP-43 leads to neuronal death and degeneration in mice, J. Clin. Invest., 121, 726, 10.1172/JCI44867 Tyagi, 2017, Inhibition of human endogenous retrovirus-K replication by antiretroviral drugs, Retrovirology, 14, 21, 10.1186/s12977-017-0347-4 Scelsa, 2005, A pilot, double-blind, placebo-controlled trial of indinavir in patients with ALS, Neurology, 64, 1298, 10.1212/01.WNL.0000156913.24701.72 Alfahad, 2013, Retroviruses and amyotrophic lateral sclerosis, Antiviral Res., 99, 180, 10.1016/j.antiviral.2013.05.006 Bowen, 2016, HIV-associated motor neuron disease: HERV-K activation and response to antiretroviral therapy, Neurology, 87, 1756, 10.1212/WNL.0000000000003258 Gonzalez-Hernandez, 2014, Regulation of the human endogenous retrovirus K (HML-2) transcriptome by the HIV-1 Tat protein, J. Virol., 88, 8924, 10.1128/JVI.00556-14 Perron, 2009, Endogenous retroviral genes, herpesviruses and gender in multiple sclerosis, J. Neurol. Sci., 286, 65, 10.1016/j.jns.2009.04.034 Makalowski, 2001, The human genome structure and organization, Acta Biochim. Pol., 48, 587, 10.18388/abp.2001_3893 Grover, 2005, ALU-ring elements in the primate genomes, Genetica, 124, 273, 10.1007/s10709-005-3086-8 Kulski, 1999, The P5 multicopy gene family in the MHC is related in sequence to human endogenous retroviruses HERV-L and HERV-16, Immunogenetics, 49, 404, 10.1007/s002510050513